Abstract: A self-biased, closed loop, low current free running oscillator clock generator method and apparatus are provided with a current mode comparator connected to a trimming resistor and configured to compare an internally generated voltage reference VREF signal to a voltage feedback signal VFB, where the current mode comparator comprises a common gate amplifier connected to a current mirror circuit in a negative self-biased closed loop to generate a control current signal for controlling a current controlled oscillator to produce an output clock signal having a clock frequency based on the control current signal, where a frequency-to-voltage converter is connected in a feedback path to receive the output clock signal and is configured to produce the voltage feedback signal VFB for input to the current mode comparator, wherein the clock frequency of the output clock signal is tuned to a nominal locked output frequency fOUT by the trimming resistor.

Abstract: A method for removing at least one pollutant from an aqueous environment comprises adding an acid to the aqueous environment to provide an acidic aqueous environment, adding a chelator solution directly to the acidic aqueous environment to achieve a precipitate of the at least one pollutant, and isolating the precipitate from the aqueous environment. The at least one pollutant may include any one or more of a heavy metal cation, an organic dye, and an active pharmaceutical ingredient.

Abstract: The present intervention identifies the antiglycating inhibitors from a series of carbazole-linked 1,2,3 triazole derivatives through in vitro MGO-mediated glycating BSA model. Derivatives 12, and 13 established a remarkable antiglycation activity at the receptor level in human monocytes. These compounds were found non-toxic, and possess the potential to halt AGE-RAGE/ROS-mediated NF-kB-dependent COX-2, and its proinflammatory product, PGE2, production in monocytes. Hence, carbazole-linked 1,2,3 triazole derivatives provide treatment modalities to delay or prevent the onset of late diabetic micro- and macro-vascular complications in diabetic patients.

Abstract: The present disclosure is concerned with substituted N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)benzamide compounds, and methods of treating and/or preventing neurodegenerative or neurocognitive disorders including, but not limited to, Alzheimer's disease, cerebral autosomal dominant arteriopathy with sub-cortical infarcts and leukoencephalopathy (CADASIL), Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS/Lou Gehrig's disease), Multiple Sclerosis, spinal muscular atrophy, spinal and bulbar muscular atrophy, familial spastic paraparesis, Machado Joseph disease, Friedreich's ataxia, Lewy body disease, and dementia (e.g., vascular dementia, Lewy body dementia, frontotemporal dementia, mixed dementia, dementia induced by Alzheimer's disease or Parkinson's disease). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: The cementitious mixture includes cement with a concentration of between about 5 wt % and about 20 wt %; powdered glass with a concentration of between about 5 wt % and about 35 wt %; fly ash with a concentration of between about 20 wt % and about 40 wt %; sand with a concentration of between about 18 wt % and about 25 wt %; a poly(carboxylate ether)-based superplasticizer with a concentration of between about 0.8 wt % and about 1.2 wt %; and water with a concentration of between about 14 wt % and about 16 wt %. Alternatively, the fly ash may be replaced with ground granulated blast furnace slag (GGBFS). The powdered glass is preferably powdered recycled glass cullet. The glass cullet may be ground to have an average particle size of about 10 ?m or less. The sand may be red dune sand, and the cement may be Portland cement or white cement. The cementitious may also include polyvinyl alcohol (PVA) microfibers.

Abstract: A method for calibrating an animation includes obtaining a static source image of a source face; capturing, by an image capturing device, a driving video of a human; determining whether a driving face, of the human, is present in each of the video frames; measuring a driving face position and a driving face size in a calibration reference frame of the driving video; generating each of one or more modified video frames based on the calibration reference frame and each of one or more subsequent video frames; and outputting, for each of the driving video frames, the source image in response to determining that the driving face is not present, and outputting the source image and the modified video frame in response to determining that the driving face is present.

Abstract: A method for calibrating an animation includes obtaining a static source image of a source face; capturing, by an image capturing device, a driving video of a human; determining whether a driving face, of the human, is present in each of the video frames; measuring a driving face position and a driving face size in a calibration reference frame of the driving video; generating each of one or more modified video frames based on the calibration reference frame and each of one or more subsequent video frames; and outputting, for each of the driving video frames, the source image in response to determining that the driving face is not present, and outputting the source image and the modified video frame in response to determining that the driving face is present.

Abstract: The present intervention identifies the antiglycating inhibitors from a series of carbazole-linked 1,2,3 triazole derivatives through in vitro MGO-mediated glycating BSA model. Derivatives 12, and 13 established a remarkable antiglycation activity at the receptor level in human monocytes. These compounds were found non-toxic, and possess the potential to halt AGE-RAGE/ROS- mediated NF- kB-dependent COX-2, and its proinflammatory product, PGE2, production in monocytes. Hence, carbazole-linked 1,2,3 triazole derivatives provide treatment modalities to delay or prevent the onset of late diabetic micro- and macro-vascular complications in diabetic patients.

Abstract: The present disclosure is concerned with substituted N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)benzamide compounds, and methods of treating and/or preventing neurodegenerative or neurocognitive disorders including, but not limited to, Alzheimer's disease, cerebral autosomal dominant arteriopathy with sub-cortical infarcts and leukoencephalopathy (CADASIL), Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS/Lou Gehrig's disease), Multiple Sclerosis, spinal muscular atrophy, spinal and bulbar muscular atrophy, familial spastic paraparesis, Machado Joseph disease, Friedreich's ataxia, Lewy body disease, and dementia (e.g., vascular dementia, Lewy body dementia, frontotemporal dementia, mixed dementia, dementia induced by Alzheimer's disease or Parkinson's disease). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: The present disclosure is concerned with N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)benzamide compounds that are capable of inhibiting SPAK kinase function, methods of treating hypoxic brain injuries due to, for example, ischemic stroke. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: The present disclosure is concerned with N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)benzamide compounds that are capable of inhibiting SPAK kinase function, methods of treating hypoxic brain injuries due to, for example, ischemic stroke. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: The present disclosure is concerned with N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)benzamide compounds that are capable of inhibiting SPAK kinase function, methods of treating hypoxic brain injuries due to, for example, ischemic stroke. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: The present disclosure is concerned with N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)benzamide compounds that are capable of inhibiting SPAK kinase function, methods of treating hypoxic brain injuries due to, for example, ischemic stroke. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: The low cement content strain-hardening cementitious composite is cement with a natural pozzolan replacing a significant portion of the Portland cement therein. The strain-hardening cementitious composite includes a mixture of cement, fly ash, sand, a polycarboxylic ether-based superplasticizer, and reinforcing polyvinyl alcohol fibers. The mixture is formed with a low content of Portland cement (6-12 wt %) and with ground scoria as the natural pozzolan (5-20%). The sand forms at least 22 wt % of the strain-hardening cementitious composite and is preferably in the form of sieved dune sand, having a silicon dioxide concentration of between approximately 80 and 90 wt %, and a feldspar concentration of between approximately 10 and 20 wt %. The dune sand is sieved such that the sand grains have a median diameter of less than or equal to approximately 300 ?m, and preferably have a median diameter of approximately 200 ?m.

Abstract: The EAFD stabilizer for returned concrete and mixer drum wash water includes various methods of using EAFD as a stabilizer in making concrete. The potentially hazardous stockpile of EAFD can be used in practical construction, which has a positive impact on the environment. A certain amount of EAFD is added to cement being mixed or to wash water and acts as a stabilizer, the wash water being used to make a cement mixture. This resultant EAFD stabilized concrete mixture stabilizes overnight.

Abstract: The fish food composition includes pea meal, corn meal, soy bean meal, corn oil, and fish meal. The fish food composition can include less than 17% by weight fish meal and between about 2.0% and 4.0% by weight pea meal. The fish food composition can also include carboxymethyl cellulose and a vitamin and mineral mix.

Abstract: The method of obtaining simulated pore water includes: mixing cement with a quantity of water and waiting a period of time for water-soluble salts in the cement to dissolve; filtering the mixture; evaporating an aliquot of the filtrate; weighing solids obtained by evaporating the aliquot to determine total dissolved solids or salts in the aliquot; weighing the remaining filtrate and measuring its volume; determining the mass of total dissolved solids in the remaining filtrate; determining the mass of water in remaining filtrate; determining the mass of water that would be in the remaining filtrate if the mix had been prepared with a desired W/C ratio; evaporating any difference between the mass of the remaining filtrate and the mass that would be present at the desired W/C; and collecting the filtrate remaining as simulated pore water for the desired W/C ratio which may be used for a variety of different applications.

Abstract: The present invention relates to the effects of Physalis minima L. methanolic extract on dyslipidemia and insulin resistance in insulin resistant high-fat diet-induced obese rats without any systemic toxicities. The extract reversed the dyslipidemia and insulin resistance in high-fat diet-induced obese rats.

Abstract: A strain-hardening cementitious composite (SHCC) can include cement, fly ash (FA), dune sand (DS), and polyvinyl alcohol (PVA) fibers. The amount of DS in the SHCC can be at least 25% by weight. The cement can be Type I ordinary Portland cement, conforming to ASTM C150 specifications. The fly ash can be Class F fly ash (FA). The median particle size of the cement can be 14 ?m. The median particle size of the FA can be 10 ?m.

Abstract: The system for measuring permeation properties of concrete and porous materials includes a chamber having an upper plate, a lower plate, and a plurality of support members, the chamber being configured for holding a specimen. A plurality of supply tubes and a plurality of discharge tubes are in fluid communication with the chamber. A gas flow measurement assembly is in fluid communication with the chamber, the gas flow measurement assembly having a first pressure gauge and a gas flow meter. A water flow measurement assembly is in fluid communication with the chamber, the water flow measurement assembly having a second pressure gauge and a water flow meter. A gas cylinder is in fluid communication with the one of the plurality of supply tubes. The system may be used to measure gas permeability, water permeability, porosity, and absorption of concrete and other porous materials.